Samuel Levy, MD


Samuel Levy is a Venture Partner at iXLife Capital.  He is the co-founder and President of Allurion Technologies.  Prior to iXLife, Dr. Levy served as an advisor at Kurma Partners and as a consultant in the Pharmaceuticals and Medical Products Management Practice at McKinsey & Company.  He also served as a business development associate at Ziopharm Oncology.  Dr. Levy graduated summa cum laude and Phi Beta Kappa from Yale College with a B.S. in Molecular Biophysics and Biochemistry. He was a Fulbright scholar at the Institut Pasteur, and graduated from Harvard Medical School.


[ Back to Team ]